A Multi-Analyte Profile (MAP) focused on the elucidation of metabolic biomarker patterns in a biological sample, such as serum or plasma. Myriad RBM’s MAP approach provides investigators with a reliable platform that can help discern these patterns in a cost-effective, efficient manner. Myriad RBM’s MetabolicMAP was designed by a major pharmaceutical company whose main interest was to glean insight into multiple metabolic pathways. This helps to expedite the go, no-go decisions made routinely in the drug development continuum.
|1. Adiponectin||2. Angiotensin-Converting Enzyme|
|3. Follicle-Stimulating Hormone||4. Glucagon-like Peptide 1, total|
|5. Insulin||6. Leptin|
|7. Luteinizing Hormone||8. Pancreatic Polypeptide|
|9. Prolactin||10. Resistin|
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|50 µL||300 µL|